Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Statistics

Total Valuation

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd has a market cap or net worth of CNY 14.66 billion. The enterprise value is 16.19 billion.

Market Cap	14.66B
Enterprise Value	16.19B

Important Dates

The next estimated earnings date is Friday, April 18, 2025.

Earnings Date	Apr 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd has 966.49 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	966.49M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.54%
Owned by Insiders (%)	26.92%
Owned by Institutions (%)	7.45%
Float	646.12M

Valuation Ratios

The trailing PE ratio is 333.72.

PE Ratio	333.72
Forward PE	n/a
PS Ratio	10.15
PB Ratio	6.33
P/TBV Ratio	6.94
P/FCF Ratio	170.26
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 81.96, with an EV/FCF ratio of 187.96.

EV / Earnings	368.42
EV / Sales	10.78
EV / EBITDA	81.96
EV / EBIT	129.91
EV / FCF	187.96

Financial Position

The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.73.

Current Ratio	1.94
Quick Ratio	1.28
Debt / Equity	0.73
Debt / EBITDA	7.74
Debt / FCF	19.77
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 1.84% and return on invested capital (ROIC) is 2.19%.

Return on Equity (ROE)	1.84%
Return on Assets (ROA)	1.95%
Return on Capital (ROIC)	2.19%
Revenue Per Employee	868,718
Profits Per Employee	25,904
Employee Count	1,696
Asset Turnover	0.32
Inventory Turnover	1.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.92% in the last 52 weeks. The beta is 0.27, so Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	-22.92%
50-Day Moving Average	15.16
200-Day Moving Average	15.78
Relative Strength Index (RSI)	47.99
Average Volume (20 Days)	25,252,928

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd had revenue of CNY 1.47 billion and earned 43.93 million in profits. Earnings per share was 0.05.

Revenue	1.47B
Gross Profit	1.09B
Operating Income	143.41M
Pretax Income	54.86M
Net Income	43.93M
EBITDA	218.14M
EBIT	143.41M
Earnings Per Share (EPS)	0.05

Full Income Statement

Balance Sheet

The company has 178.49 million in cash and 1.70 billion in debt, giving a net cash position of -1.52 billion or -1.58 per share.

Cash & Cash Equivalents	178.49M
Total Debt	1.70B
Net Cash	-1.52B
Net Cash Per Share	-1.58
Equity (Book Value)	2.32B
Book Value Per Share	3.76
Working Capital	538.72M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 112.78 million and capital expenditures -26.67 million, giving a free cash flow of 86.11 million.

Operating Cash Flow	112.78M
Capital Expenditures	-26.67M
Free Cash Flow	86.11M
FCF Per Share	0.09

Full Cash Flow Statement

Margins

Gross margin is 74.27%, with operating and profit margins of 9.73% and 2.98%.

Gross Margin	74.27%
Operating Margin	9.73%
Pretax Margin	3.72%
Profit Margin	2.98%
EBITDA Margin	14.81%
EBIT Margin	9.73%
FCF Margin	5.84%

Dividends & Yields

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	189.65%
Buyback Yield	12.57%
Shareholder Yield	12.57%
Earnings Yield	0.33%
FCF Yield	0.59%

Stock Splits

The last stock split was on May 25, 2001. It was a forward split with a ratio of 1.5.

Last Split Date	May 25, 2001
Split Type	Forward
Split Ratio	1.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a